| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.512 | 14.846 | 13.850 | 16.892 | 19.003 | 14.376 | 19.019 | 18.460 | 23.524 | 15.636 |
| Total Income - EUR | 9.512 | 14.868 | 13.850 | 16.892 | 19.003 | 14.377 | 19.036 | 28.481 | 23.524 | 30.631 |
| Total Expenses - EUR | 7.234 | 6.306 | 7.964 | 9.510 | 8.315 | 13.194 | 16.744 | 26.783 | 21.060 | 45.399 |
| Gross Profit/Loss - EUR | 2.277 | 8.562 | 5.886 | 7.382 | 10.687 | 1.183 | 2.292 | 1.698 | 2.464 | -14.768 |
| Net Profit/Loss - EUR | 1.992 | 8.116 | 5.470 | 6.882 | 10.117 | 916 | 1.876 | 1.091 | 1.975 | -14.768 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Promed Sib S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.490 | 1.475 | 1.450 | 2.458 | 2.993 | 21.050 | 15.365 | 23.045 | 17.652 | 2.491 |
| Current Assets | 3.591 | 8.084 | 5.659 | 7.125 | 10.004 | 2.050 | 2.618 | 3.424 | 5.919 | 11.854 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.911 | 679 | 253 |
| Receivables | 3.124 | 7.282 | 3.708 | 4.979 | 7.140 | 914 | 1.011 | 454 | 350 | 1.825 |
| Cash | 468 | 803 | 1.951 | 2.145 | 2.864 | 1.136 | 1.608 | 1.059 | 4.891 | 9.775 |
| Shareholders Funds | 3.973 | 8.161 | 5.523 | 6.933 | 11.815 | 7.441 | 9.153 | 8.929 | 10.876 | -3.953 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.193 | 1.399 | 1.586 | 2.649 | 1.267 | 16.454 | 8.831 | 20.493 | 14.021 | 18.883 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5520 - 5520" | |||||||||
| CAEN Financial Year |
5520
|
|||||||||
Comments - Promed Sib S.r.l.